Recently, Essers and Radebold (5) described a rapid slide agglutination test with plasma-coated latex for the simultaneous detection of clumping factor and protein A. In principle, plasma contains fibrinogen, which has the capacity to bind to clumping factor, and immunoglobulin, which has the capacity to bind to protein A through its Fc fragment. Hence, the presence of either clumping factor or protein A on the bacterial cell results in coagglutination of cells and latex particles. More recently, Flandrois and Carret (6) described a rapid slide hemagglutination test with fibrinogensensitized sheep erythrocytes for the sole detection of clumping factor.
Since these original publications, three commercially available products have been developed: two latex agglutination tests, SeroSTAT Staph (Scott Laboratories, Inc.) and Staphylatex (American Micro Scan); and one hemagglutination test, Staphyloslide (BBL Microbiology Systems).
At this writing, three evaluations (3, 8, 12) for the conventional use of the SeroSTAT product and one evaluation for the use of this product for the identification of S. aureus in blood culture fluid (4) The SeroSTAT test was performed by placing one drop of kit-supplied physiological saline on a circle on an agglutination slide. A short sweep of confluent growth was suspended in one drop of saline to give a homogeneous suspension. One drop of kit reagent was added to the suspension and mixed with a wooden applicator stick. The slide was rotated by hand for 45 s, after which the suspension was observed for agglutination. A saline-latex reagent control was performed with each run and concurrently with any test deemed equivocal.
The Staphylatex test was performed by placing one drop of kit-supplied physiological saline on a circle on a kitsupplied agglutination card. Three to four colonies of growth were suspended in the drop of saline with a bacteriological loop to give a homogeneous suspension. One drop of kit wooden applicator stick. The card was rotated by hand for 45 s, after which the suspension was observed for agglutination. A saline-latex reagent control was performed with each run and concurrently with any test deemed equivocal.
The Staphyloslide test was performed after carefully suspending vials of sensitized and nonsensitized erythrocytes. One drop of each suspension was placed in one of two wax pencil rings drawn on a clean microscope slide. Three to four colonies of growth were suspended in each drop with a wooden applicator stick. The slide was rocked by hand for 15 s, after which each suspension was observed for hemagglutination.
Tube coagulase test. Approximately 0.1 ml of a brain heart infusion broth (Difco Laboratories) culture incubated overnight at 35°C was added to tubes containing 0.5 ml of freshly reconstituted EDTA-rabbit plasma (Difco). The tubes were observed for clot formation after 4 h of incubation in a 37°C water bath (4-h tube coagulase test) and, when negative, again after overnight incubation at room temperature (24-h tube coagulase test). Any degree of clot formation was considered to constitute a positive test.
Slide coagulase test. A heavy, homogeneous suspension of growth was made in a drop of distilled water on a glass slide, to which was added a drop of pooled EDTA-human plasma collected from laboratory personnel the day of testing. The two drops were mixed with a bacteriological needle and observed for clumping after 15 s. Any degree of clumping was considered to constitute a positive reaction.
Thermonuclease test. Thermostable nuclease activity was determined by the method of Lachica et al. (10) . In brief, the same brain heart infusion broth culture used for the tube coagulase test was heated in a boiling water bath for 15 min. A precut 3-mm well in toluidine blue-DNA agar (pH 9.0) layered in petri dishes was filled with 30 ,ul of the brain heart infusion culture. The plates were incubated at 35°C, and the wells were read at 4 and 24 h for the presence of pink halos indicative of nuclease activity.
Mannitol fermentation. The ability of isolates to utilize mannitol under anaerobic conditions was determined by the method recommended by the Subcommittee of Taxonomy of Staphylococci and Micrococci (13) . All tubes were boiled and cooled before use to remove excess oxygen. Mineral oil was used as an overlay.
API Staph-Ident profile determinations. Staph-Ident profiles were determined by the procedure recommended by the manufacturer as described in the product insert.
Novobiocin susceptibility test. Novobiocin susceptibility testing was performed by the standard Kirby-Bauer procedure; a zone size of s16 mm was considered to be indicative of resistance (1) .
RESULTS
Of the 354 isolates tested, 156 were identified as S. aureus by the three agglutination tests and by the 4-and 24-h tube coagulase tests, whereas 187 isolates were identified as NSaMs by all five tests (Table 1) . Of these 187 NSaMs strains, 7 produced adherent colonies and would not suspend uniformly in saline. When mixed with agglutination reagents, these suspensions produced no additional clumping appearance and were regarded as negative for the reactions, an interpretation consistent with the tube coagulase results.
Eleven isolates yielded results with discrepancies among the five tests and were further characterized by the thermonuclease, mannitol fermentation, and slide coagulase tests (Table 1) as S. aureus (nine) or NSaMs (two). Isolates with positive tube coagulase and thermonuclease tests were designated as S. aureus, and isolates that were negative for these tests were designated as NSaMs. Four isolates which were tube coagulase negative after 4 h of incubation but turned positive after overnight incubation produced thermonuclease, mannitol fermentation, and slide coagulase reactions consistent with S. aureus and were designated as such. All four of these strains were properly identified by the agglutination tests. One isolate was negative for 4-and 24-h tube coagulase tests but yielded thermonuclease, mannitol fermentation and slide coagulase test results consistent with S. aureus. All three agglutination tests properly identified this strain. The four isolates designated as S. aureus and showing one or more negative agglutination reactions also yielded false-negative slide coagulase tests. The Staphyloslide test produced uninterpretable results for two strains, which were designated as NSaMs because both sensitized and nonsensitized erythrocytes agglutinated when mixed with culture. Both strains were identified as S. saprophyticus by the API Staph-Ident (2000 profile), supplemented with the novobiocin susceptibility test (data not shown).
Identification of the 11 isolates that yielded inconsistent agglutination and tube coagulase results as S. aureus and NSaMs allowed for the determination of total true-and falsepositives and true-and false-negatives and, hence, the calculation of sensitivity, specificity, predictive value of a positive result (PV+), and predictive value of a negative result (PV-) for each test ( perature incubation based on their observation that occasional isolates of S. aureus will not produce free coagulase at 36°C (11) . Our analysis of the three agglutination products included comparison of agglutination results with the 4-and 24-h tube coagulase tests.
Of the 354 isolates tested, 11 (9 S. aureus and 2 NSaMs) yielded results with discrepancies among the five tests. Of these 11 isolates, 5 S. aureus strains exhibited false-negative 4 All three commercial agglutination tests yield rapid and reliable results and are easy to perform. Identifications may be performed on organisms taken directly from a primary plate when sufficient growth is present. A rapid and reliable differentiation of S. aureus and NSaMs not only allows for faster reporting but, in at least some cases, also eliminates unnecessary antibiotic susceptibility testing. This study also demonstrates the increased sensitivity of the tube coagulase test when tests that are negative after 4 h are retained for overnight, room-temperature incubation.
